Share on

Asia Pacific Extracorporeal Membrane Oxygenation Machine Market Research Report – By Modality, Application & Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore & Rest of APAC) - Industry Analysis, Size, Share, Growth, Trends & Forecasts (2022 to 2027)

Published: March, 2023
ID: 4800
Pages: 145
Formats: report pdf report excel report power bi report ppt

Asia Pacific Extracorporeal Membrane Oxygenation Machine Market Size & Growth (2022 to 2027):

The Extracorporeal Membrane Oxygenation Machine Market in the Asia Pacific is valued at USD 51.05 million in 2022 and is expected to reach USD 66.56 million by 2027, growing at a CAGR of 5.45% during the forecast period 2022 to 2027.

Extracorporeal membrane oxygenation (ECMO) was first coined to describe long-term extracorporeal support that emphasized oxygenation. After that, the focus turned to carbon dioxide removal in some patients, leading to the coining of the term extracorporeal carbon dioxide removal.

Later, Extracorporeal support was used to help patients who had undergone heart surgery after their procedures. Over the last few years, different capabilities have been studied and deployed, making it a powerful instrument in clinicians' arsenal of life and organ support measures. With so many applications for extracorporeal circuitry, a new name, extracorporeal life support, has emerged to characterize it. 

The rise in the number of cases of cardiovascular and respiratory diseases, the adoption of ECMO as a bridge to lung transplantation, the growing number of ECMO centers, conferences, and training programs to raise awareness among the senior population in the region, and the number of people suffering from diseases in populous countries are all contributing to the market's growth.

Furthermore, an increase in the adoption of unhealthy lifestyles and the resulting development of lifestyle diseases is expected to increase the COPD incidence rate. Identified risk factors, such as the rising tobacco consumption among men and women, are fuelling the market's expansion.

Accidents resulting in technical failure, infections, and bleeding during treatment hinder the market expansion. Moreover, the demand for extracorporeal membrane oxygenation machines faces constraints such as a scarcity of experienced specialists and expensive therapy costs. Therefore, a few hurdles must be overcome to penetrate the market effectively. First, there are minimal issues related to the devices due to a lack of competent labor. Second, the usage of this equipment increases the risk of respiratory illnesses. And this is the core issue that has to be addressed.

This research report on the Asia Pacific Extracorporeal Membrane Oxygenation Machine Market has been segmented and sub-segmented into the following categories.

By Modality:

  • Veno-Arterial (VA)
  • Veno-Venous (VV)
  • Arterio-Venous (AV)

By Application:

  • Respiratory
  • Cardiac
  • Extracorporeal Cardiopulmonary Resuscitation (ECPR)

By Country:

  • India
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Thailand
  • Malaysia
  • Vietnam
  • Philippines
  • Indonesia
  • Singapore
  • Rest of APAC

The Asia Pacific region is expected to grow faster, boosting revenue for ECMO machine manufacturers. The Asia Pacific extracorporeal membrane oxygenation machine market is being driven by a large population and a high incidence of severe cardiorespiratory diseases. The extracorporeal membrane oxygenation machine market is dominated by China, Japan, Australia, and India.

The market in this region is developing due to factors such as good reimbursement scenarios in Japan, rising cardiovascular diseases in China, in India, the use and usage of extracorporeal membrane oxygenation equipment is expanding, while cardiopulmonary problems are on the rise in Australia.

The China ECMO Market is growing steadily, owing to the country's substantial patient population and rising healthcare spending. In addition, the government has a high frequency of respiratory and heart disease patients. Increasing public awareness of ECMO systems and the rising prevalence of chronic respiratory disorders such as chronic obstructive pulmonary disease (COPD) and asthma are expected to propel the market forward in the future years. In addition, the growing number of ECLS cases and centers in China leads to the growth of the market being investigated in the country.

The growing Japan ECMO Market has been fueled by rising medical costs, an alarming rise in cardiovascular disorders, an aging population, and the easy availability of cutting-edge medical facilities.

Key Market Companies dominating the Asia Pacific Extracorporeal Membrane Oxygenation Machine Market Profiled in the Report are Getinge Group, Medtronic plc, LivaNova PLC, XENIOS AG, Terumo Corporation, MicroPort Scientific Corporation, NIPRO Corporation, OriGen Biomedical Inc., ALung Technologies Inc., and EUROSETS S.r.l.,

Please wait. . . . Your request is being processed

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000

Didn’t find what you’re looking for?

Need something within your budget?


Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us:

Click for Request Sample